Ikena Oncology Inc (IKNA)
1.69
-0.02
(-1.17%)
USD |
NASDAQ |
Nov 15, 16:00
1.68
-0.01
(-0.59%)
After-Hours: 20:00
Ikena Oncology Enterprise Value: -56.48M for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | -56.48M |
| November 14, 2024 | -55.51M |
| November 13, 2024 | -54.06M |
| November 12, 2024 | -53.10M |
| November 11, 2024 | -53.58M |
| November 08, 2024 | -53.10M |
| November 07, 2024 | -56.48M |
| November 06, 2024 | -55.03M |
| November 05, 2024 | -56.48M |
| November 04, 2024 | -55.03M |
| November 01, 2024 | -55.03M |
| October 31, 2024 | -55.51M |
| October 30, 2024 | -55.99M |
| October 29, 2024 | -55.51M |
| October 28, 2024 | -55.03M |
| October 25, 2024 | -55.03M |
| October 24, 2024 | -55.51M |
| October 23, 2024 | -56.48M |
| October 22, 2024 | -56.48M |
| October 21, 2024 | -56.48M |
| October 18, 2024 | -55.51M |
| October 17, 2024 | -55.51M |
| October 16, 2024 | -55.03M |
| October 15, 2024 | -55.51M |
| October 14, 2024 | -55.03M |
| Date | Value |
|---|---|
| October 11, 2024 | -55.03M |
| October 10, 2024 | -55.03M |
| October 09, 2024 | -55.51M |
| October 08, 2024 | -55.99M |
| October 07, 2024 | -56.48M |
| October 04, 2024 | -55.99M |
| October 03, 2024 | -57.44M |
| October 02, 2024 | -56.96M |
| October 01, 2024 | -55.99M |
| September 30, 2024 | -54.55M |
| September 27, 2024 | -61.93M |
| September 26, 2024 | -62.42M |
| September 25, 2024 | -63.38M |
| September 24, 2024 | -63.38M |
| September 23, 2024 | -63.86M |
| September 20, 2024 | -62.90M |
| September 19, 2024 | -62.90M |
| September 18, 2024 | -65.31M |
| September 17, 2024 | -64.83M |
| September 16, 2024 | -62.42M |
| September 13, 2024 | -63.86M |
| September 12, 2024 | -63.38M |
| September 11, 2024 | -62.90M |
| September 10, 2024 | -63.86M |
| September 09, 2024 | -63.38M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-132.75M
Minimum
Nov 09 2023
944.32M
Maximum
Mar 26 2021
39.12M
Average
-11.25M
Median
Oct 13 2023
Enterprise Value Benchmarks
| MediciNova Inc | 45.42M |
| NovaBay Pharmaceuticals Inc | 2.764M |
| Palatin Technologies Inc | 8.735M |
| iBio Inc | 6.468M |
| Theriva Biologics Inc | -13.32M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.23M |
| Total Expenses (Quarterly) | 11.60M |
| EPS Diluted (Quarterly) | -0.21 |
| Earnings Yield | -72.19% |
| Normalized Earnings Yield | -106.37 |